Effects of different amino-acid substitutions in the leucine 694-proline 708 segment of recombinant von Willebrand factor
- 1 December 1995
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 91 (4) , 983-990
- https://doi.org/10.1111/j.1365-2141.1995.tb05423.x
Abstract
Type 2B von Willebrand disease (vWD) is characterized by an increased affinity of von Willebrand factor (vWF) for binding to platelet glycoprotein Ib (GpIb). Most type 2B candidate mutations are clustered in the 509-695 disulphide loop but three of them (H505D, L697V and A698V) are outside this loop. We confirm here that the A698V mutation is a type 2B mutation by its expression in Cos-7 cells. As the L697V and A698V type 2B mutations both induce the presence of a valine residue in the 694-708 sequence, we created and expressed different mutated recombinant vWFs (rvWFs), in substituting the other leucine and alanine residues of this sequence (at positions 694, 701 and 706) into valine resides. V694rvWF and V706rvWF displayed decreased ristocetin-induced GpIb binding showing that it is not always the presence of a valine residue that may explain the increased affinity of type 2B vWF for GpIb. We also compared the interaction with platelets of V697rvWF and V698rvWF to those obtained with rvWFs reproducing two prevalent type 2B mutations located in the loop (R543W and V553M). We show that the two mutations located in the loop are more reactive than the two mutations identified outside the loop.Keywords
This publication has 18 references indexed in Scilit:
- Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetinBiochemistry, 1992
- Sequencing of the primary adhesion domain of bovine von Willebrand factorBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1992
- Chromatographic Preparation of a Therapeutic Highly Purified von Willebrand Factor Concentrate from Human CryoprecipitateVox Sanguinis, 1992
- Comparison of the primary structure of the functional domains of human and porcine von Willebrand factor that mediate platelet adhesionBiochemical and Biophysical Research Communications, 1992
- In vitro Evaluation of a Very‐High‐Purity, Solvent/Detergent‐Treated, Von Willebrand Factor ConcentrateVox Sanguinis, 1991
- The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain.Journal of Clinical Investigation, 1991
- Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complexBiochemistry, 1989
- von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets.Proceedings of the National Academy of Sciences, 1989
- Variant von Willebrand's DiseaseJournal of Clinical Investigation, 1980
- Human blood platelet adhesion to artery subendothelium is mediated by factor VIII–Von Willebrand factor bound to the subendotheliumNature, 1979